Basic Information
ID DDInter1007
Drug Type small molecule
Molecular Formula C13H16ClNO
Molecular Weight 237.725
CAS Number 6740-88-1
Description Ketamine is an NMDA receptor antagonist with a potent anesthetic effect.[A31869] It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic effects. It was FDA approved in 1970, and from there, it has been used as an anesthetic for children or patients undergoing minor surgeries but mainly for veterinary purposes.[L1332]
ATC Classification N01AX03
IUPAC Name 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
InChI YQEZLKZALYSWHR-UHFFFAOYSA-N
Canonical SMILES CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Useful Links DrugBank ChEBI PubChem Substance KEGG Compound KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Wikipedia ChEMBL
Interactions with Ketamine
Filter:
Severity level ID Name Mechanism Detail
Interactions with diseases
Filter:
Severity level Disease name Text References
Interactions with foods
Filter:
Severity level Food name Description Management Mechanism References
Interactions with compound preparation
Multi-DRUG trade Multi-DRUG Drug type Warning Note